Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone - Institut Gustave Roussy
Journal Articles Lancet Oncology Year : 2024

Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone

Abstract

No abstract available

Domains

Cancer Methods and statistics Statistics [stat] Other Statistics [stat.ML] Methodology [stat.ME]
Embargoed file
Embargoed file
Visibility date is undetermined

Camille Dumont  : Connect in order to contact the contributor

https://inserm.hal.science/inserm-04714848

Submitted on : Monday, September 30, 2024-3:12:35 PM

Last modification on : Tuesday, October 8, 2024-6:39:19 PM

Embargoed file

Please log in to request access to the document

Dates and versions

inserm-04714848 , version 1 (30-09-2024)

Licence

Copyright

Identifiers

Cite

F Anthony Greco, Chris Labaki, Elie Rassy. Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone. Lancet Oncology, 2024, 25 (8), pp.955-956. ⟨10.1016/S1470-2045(24)00344-9⟩. ⟨inserm-04714848⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM CESP FNCLCC IGR UVSQ UNIV-PARIS-SACLAY GS-SANTE-PUBLIQUE ONCOSTAT
34 View
2 Download

Altmetric

Share

More